These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35590152)

  • 1. Integrating functional genomics with genetics to understand the biology of ALS and FTD.
    Cruchaga C
    Med; 2022 Apr; 3(4):226-227. PubMed ID: 35590152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C9orf72 and UNC13A are shared risk loci for amyotrophic lateral sclerosis and frontotemporal dementia: a genome-wide meta-analysis.
    Diekstra FP; Van Deerlin VM; van Swieten JC; Al-Chalabi A; Ludolph AC; Weishaupt JH; Hardiman O; Landers JE; Brown RH; van Es MA; Pasterkamp RJ; Koppers M; Andersen PM; Estrada K; Rivadeneira F; Hofman A; Uitterlinden AG; van Damme P; Melki J; Meininger V; Shatunov A; Shaw CE; Leigh PN; Shaw PJ; Morrison KE; Fogh I; Chiò A; Traynor BJ; Czell D; Weber M; Heutink P; de Bakker PI; Silani V; Robberecht W; van den Berg LH; Veldink JH
    Ann Neurol; 2014 Jul; 76(1):120-33. PubMed ID: 24931836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cracking the cryptic code in amyotrophic lateral sclerosis and frontotemporal dementia: Towards therapeutic targets and biomarkers.
    Akiyama T; Koike Y; Petrucelli L; Gitler AD
    Clin Transl Med; 2022 May; 12(5):e818. PubMed ID: 35567447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryptic inclusions UNCover losses driving neurodegeneration.
    Bademosi AT; Walker AK
    Trends Genet; 2022 Sep; 38(9):889-891. PubMed ID: 35773026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and immunopathological analysis of CHCHD10 in Australian amyotrophic lateral sclerosis and frontotemporal dementia and transgenic TDP-43 mice.
    McCann EP; Fifita JA; Grima N; Galper J; Mehta P; Freckleton SE; Zhang KY; Henden L; Hogan AL; Chan Moi Fat S; Wu SS; Jagaraj CJ; Berning BA; Williams KL; Twine NA; Bauer D; Piguet O; Hodges J; Kwok JBJ; Halliday GM; Kiernan MC; Atkin J; Rowe DB; Nicholson GA; Walker AK; Blair IP; Yang S
    J Neurol Neurosurg Psychiatry; 2020 Feb; 91(2):162-171. PubMed ID: 31690696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying risk loci for FTD and shared genetic component with ALS: A large-scale multitrait association analysis.
    Chen K; Gao T; Liu Y; Zhu K; Wang T; Zeng P
    Neurobiol Aging; 2024 Feb; 134():28-39. PubMed ID: 37979250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective Genetic Overlap Between Amyotrophic Lateral Sclerosis and Diseases of the Frontotemporal Dementia Spectrum.
    Karch CM; Wen N; Fan CC; Yokoyama JS; Kouri N; Ross OA; Höglinger G; Müller U; Ferrari R; Hardy J; Schellenberg GD; Sleiman PM; Momeni P; Hess CP; Miller BL; Sharma M; Van Deerlin V; Smeland OB; Andreassen OA; Dale AM; Desikan RS;
    JAMA Neurol; 2018 Jul; 75(7):860-875. PubMed ID: 29630712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TDP-43 represses cryptic exon inclusion in the FTD-ALS gene UNC13A.
    Ma XR; Prudencio M; Koike Y; Vatsavayai SC; Kim G; Harbinski F; Briner A; Rodriguez CM; Guo C; Akiyama T; Schmidt HB; Cummings BB; Wyatt DW; Kurylo K; Miller G; Mekhoubad S; Sallee N; Mekonnen G; Ganser L; Rubien JD; Jansen-West K; Cook CN; Pickles S; Oskarsson B; Graff-Radford NR; Boeve BF; Knopman DS; Petersen RC; Dickson DW; Shorter J; Myong S; Green EM; Seeley WW; Petrucelli L; Gitler AD
    Nature; 2022 Mar; 603(7899):124-130. PubMed ID: 35197626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal Fluid TAR DNA-Binding Protein 43 Combined with Tau Proteins as a Candidate Biomarker for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Spectrum Disorders.
    Bourbouli M; Rentzos M; Bougea A; Zouvelou V; Constantinides VC; Zaganas I; Evdokimidis I; Kapaki E; Paraskevas GP
    Dement Geriatr Cogn Disord; 2017; 44(3-4):144-152. PubMed ID: 28848086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear transport dysfunction: a common theme in amyotrophic lateral sclerosis and frontotemporal dementia.
    Jovičić A; Paul JW; Gitler AD
    J Neurochem; 2016 Aug; 138 Suppl 1():134-44. PubMed ID: 27087014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryptic splicing of stathmin-2 and UNC13A mRNAs is a pathological hallmark of TDP-43-associated Alzheimer's disease.
    Agra Almeida Quadros AR; Li Z; Wang X; Ndayambaje IS; Aryal S; Ramesh N; Nolan M; Jayakumar R; Han Y; Stillman H; Aguilar C; Wheeler HJ; Connors T; Lopez-Erauskin J; Baughn MW; Melamed Z; Beccari MS; Olmedo Martínez L; Canori M; Lee CZ; Moran L; Draper I; Kopin AS; Oakley DH; Dickson DW; Cleveland DW; Hyman BT; Das S; Ertekin-Taner N; Lagier-Tourenne C
    Acta Neuropathol; 2024 Jan; 147(1):9. PubMed ID: 38175301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TBK1 mutation frequencies in French frontotemporal dementia and amyotrophic lateral sclerosis cohorts.
    Le Ber I; De Septenville A; Millecamps S; Camuzat A; Caroppo P; Couratier P; Blanc F; Lacomblez L; Sellal F; Fleury MC; Meininger V; Cazeneuve C; Clot F; Flabeau O; LeGuern E; Brice A;
    Neurobiol Aging; 2015 Nov; 36(11):3116.e5-3116.e8. PubMed ID: 26476236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The emerging roles of microRNAs in the pathogenesis of frontotemporal dementia-amyotrophic lateral sclerosis (FTD-ALS) spectrum disorders.
    Gascon E; Gao FB
    J Neurogenet; 2014; 28(1-2):30-40. PubMed ID: 24506814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Family-based exome sequencing identifies RBM45 as a possible candidate gene for frontotemporal dementia and amyotrophic lateral sclerosis.
    van der Zee J; Dillen L; Baradaran-Heravi Y; Gossye H; Koçoğlu C; Cuyt I; Dermaut B; Sieben A; Baets J; De Jonghe P; Vandenberghe R; De Deyn P; Cras P; Engelborghs S; Van Broeckhoven C;
    Neurobiol Dis; 2021 Aug; 156():105421. PubMed ID: 34118419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics insight into the amyotrophic lateral sclerosis/frontotemporal dementia spectrum.
    Ji AL; Zhang X; Chen WW; Huang WJ
    J Med Genet; 2017 Mar; 54(3):145-154. PubMed ID: 28087719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Mechanisms of Neurodegeneration Related to
    Babić Leko M; Župunski V; Kirincich J; Smilović D; Hortobágyi T; Hof PR; Šimić G
    Behav Neurol; 2019; 2019():2909168. PubMed ID: 30774737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid in vitro quantification of TDP-43 and FUS mislocalisation for screening of gene variants implicated in frontotemporal dementia and amyotrophic lateral sclerosis.
    Oyston LJ; Ubiparipovic S; Fitzpatrick L; Hallupp M; Boccanfuso LM; Kwok JB; Dobson-Stone C
    Sci Rep; 2021 Jul; 11(1):14881. PubMed ID: 34290285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis/genetics of frontotemporal dementia and how it relates to ALS.
    Bennion Callister J; Pickering-Brown SM
    Exp Neurol; 2014 Dec; 262 Pt B():84-90. PubMed ID: 24915640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ALS Genes in the Genomic Era and their Implications for FTD.
    Nguyen HP; Van Broeckhoven C; van der Zee J
    Trends Genet; 2018 Jun; 34(6):404-423. PubMed ID: 29605155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward genetic counseling practice standards for diagnostic testing in amyotrophic lateral sclerosis and frontotemporal dementia.
    Crook A; Jacobs C; Newton-John T; McEwen A
    Amyotroph Lateral Scler Frontotemporal Degener; 2022 Nov; 23(7-8):562-574. PubMed ID: 35343344
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.